Lu, Z. John; Comanor, William S. - In: The Review of Economics and Statistics 80 (1998) 1, pp. 108-118
This paper provides empirical evidence on the leading factors affecting the prices of new pharmaceuticals, both at introduction and after 4, 6, and 8 years. Most important is the extent of therapeutic advance embodied in a new product. For drugs which represent important therapeutic gains,...